Showing results (1141-1150 of 1,179) with videos related to

Sort By:
Pageof 118
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster seraWei Wang, Gitanjali L Bhushan, Stephanie Paz, et al.
Substance Use & Addiction Journal|July 21, 2026
Learning Collaboratives in the HEALing Communities Study: An Approach to Providing Training and Technical AssistanceMaria Rudorf, Trevor Baker, Curtis Walker, et al.
Iscience|July 18, 2024
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept studyTewodros Mulugeta Dagnew, Chieh-En J Tseng, Chi-Hyeon Yoo, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Nature Medicine|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim resultsAndras Heczey, Xin Xu, Amy N Courtney, et al.
Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Journal of Emergency Nursing|July 14, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy TrialThomas Cash, Araz Marachelian, Steven G DuBois, et al.
Pageof 118